Epizyme

EPZM

EPZM
Epizyme Stock Quote
$15.16 -$0.01 -0.1%
Price as of July 10, 2020, 4:30 p.m. EDT View Interactive EPZM Charts

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

Interactive Chart


News & Analysis: Epizyme

All

Market Moves

Earnings





Here's Why Epizyme Lost 27.6% in March

Investors were looking forward to the drug company's transition to commercial operations, but the coronavirus pandemic could delay the maturation process.